Clinical efficacy of repeated fecal microbiota transplantation (FMT) in chronic active and therapy refractory ulcerative colitis.

Not Applicable

• Conditions: K51; Ulcerative colitis

• Registration Number: DRKS00005331
• Lead Sponsor: Klinische Abteilung für GastroenterologieKlinik für Innere MedizinMedizinische Universität Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-12-29
• Study Completion: 2014-06-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

chronic active UC, ongoing therapy on stable dose for at least 14 days, signed informed consent

Exclusion Criteria

pregnancy, malignancy, other chronic diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of disease activity presented in a decrease of the total Mayo score of at least 3 points at day 90 (end of follow up)

Secondary Outcome Measures

Name	Time	Method
Changes of Inflammatory parameters before (day 1) and after (day 3, 14, 28, 42, 56 and 90) FMT.<br>Safety Aspects of FMT in chronic active UC.